Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A word to the wise about ketamine.

Literature DB >> 24585328

A word to the wise about ketamine.

Alan F Schatzberg.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2014 PMID： 24585328 DOI： 10.1176/appi.ajp.2014.13101434

Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

Review 1. Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Authors: Marc S Lener; Bashkim Kadriu; Carlos A Zarate
Journal: Drugs Date: 2017-03 Impact factor: 9.546

Review 2. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Authors: Gerard Sanacora; Alan F Schatzberg
Journal: Neuropsychopharmacology Date: 2014-09-26 Impact factor: 7.853

Review 3. Clinical applications of hallucinogens: A review.

Authors: Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal: Exp Clin Psychopharmacol Date: 2016-08 Impact factor: 3.157

4. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

Authors: Dawn F Ionescu; David A Luckenbaugh; Mark J Niciu; Erica M Richards; Carlos A Zarate
Journal: Bipolar Disord Date: 2014-11-14 Impact factor: 6.744

5. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Authors: Nolan R Williams; Boris D Heifets; Christine Blasey; Keith Sudheimer; Jaspreet Pannu; Heather Pankow; Jessica Hawkins; Justin Birnbaum; David M Lyons; Carolyn I Rodriguez; Alan F Schatzberg
Journal: Am J Psychiatry Date: 2018-08-29 Impact factor: 18.112

Review 6. Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.

Authors: Samuel T Wilkinson; Paul E Holtzheimer; Shan Gao; David S Kirwin; Rebecca B Price
Journal: Biol Psychiatry Date: 2018-09-20 Impact factor: 13.382

A word to the wise about ketamine.

Review 1. Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Review 2. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Review 3. Clinical applications of hallucinogens: A review.

4. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

5. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Review 6. Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.

Review 7. Does ketamine have anti-suicidal properties? Current status and future directions.

8. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Review 9. Proceed with caution: off-label ketamine treatment for major depressive disorder.

10. From Mice to Men: Can Ketamine Enhance Resilience to Stress?